Clinical and Radiological Findings of Autosomal Dominant Osteopetrosis Type II: A Case Report

被引:7
|
作者
Kant, Priyanka [1 ]
Sharda, Neelkamal [1 ]
Bhowate, Rahul R. [2 ]
机构
[1] Manav Rachna Dent Coll, Dept Oral Med & Radiol, Sector 43,Aravalli Hills,Delhi-Surajkund Rd, Faridabad 121001, Haryana, India
[2] Sharad Pawar Dent Coll & Hosp, Dept Oral Med & Radiol, Wardha 442001, Maharashtra, India
关键词
D O I
10.1155/2013/707343
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Osteopetrosis is a rare inherited genetic disease characterized by sclerosis of the skeleton caused by the absence or malfunction of osteoclasts. Three distinct forms of the disease have been recognized, autosomal dominant osteopetrosis being the most common. Autosomal dominant osteopetrosis exhibits a heterogeneous trait with milder symptoms, often at later childhood or adulthood. The aim of this case report is to present the clinical and radiographic features of a 35-year-old female patient with autosomal dominant osteopetrosis type II who exhibited features of chronic generalised periodontitis, and the radiographs revealed generalised osteosclerosis and hallmark radiographic features of ADO type II, that is, " bone-within-bone appearance" and "Erlenmeyer-flask deformity."
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study
    Wang, Ziyuan
    Li, Xiang
    Wang, Ya
    Fu, Wenzhen
    Liu, Yujuan
    Zhang, Zhenlin
    Wang, Chun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [32] Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier
    Takacs, I
    Cooper, H
    Weaver, DD
    Econs, MJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 85 (01): : 9 - 12
  • [33] AUTOSOMAL DOMINANT OSTEOPETROSIS TYPE-II WITH MALIGNANT PRESENTATION - FURTHER SUPPORT FOR HETEROGENEITY
    WALPOLE, IR
    NICOLL, A
    GOLDBLATT, J
    CLINICAL GENETICS, 1990, 38 (04) : 257 - 263
  • [34] Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II)
    Butscheidt, Sebastian
    Rolvien, Tim
    Kornak, Uwe
    Schmidt, Felix N.
    Schinke, Thorsten
    Amling, Michael
    Oheim, Ralf
    CALCIFIED TISSUE INTERNATIONAL, 2018, 102 (01) : 41 - 52
  • [35] Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II)
    Sebastian Butscheidt
    Tim Rolvien
    Uwe Kornak
    Felix N. Schmidt
    Thorsten Schinke
    Michael Amling
    Ralf Oheim
    Calcified Tissue International, 2018, 102 : 41 - 52
  • [36] Genotype-phenotype correlation in patients presenting with type II autosomal dominant osteopetrosis (ADO II)
    Taranta, A
    DiGiacinto, C
    DelFattore, A
    Recchia, I
    Spera, G
    Falcone, S
    Teti, A
    Migliaccio, S
    BONE, 2004, 34 : S28 - S28
  • [37] Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study
    Polgreen, Lynda E.
    Villa-Lopez, Eva
    Chen, Liz
    Liu, Ziyue
    Katz, Amy
    Parks-Schenck, Corinne
    Hart, Marian
    Imel, Erik A.
    Econs, Michael J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [38] A Case of Autosomal Dominant Osteopetrosis Type 2 with a CLCN7 Gene Mutation
    Kang, Sol
    Kang, Young Kyung
    Lee, Jun Ah
    Kim, Dong Ho
    Lim, Jung Sub
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2019, 11 (04) : 439 - 443
  • [39] Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients
    Pang, Q.
    Chi, Y.
    Zhao, Z.
    Xing, X.
    Li, M.
    Wang, O.
    Jiang, Y.
    Liao, R.
    Sun, Y.
    Dong, J.
    Xia, W.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (03) : 1047 - 1055
  • [40] Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients
    Q. Pang
    Y. Chi
    Z. Zhao
    X. Xing
    M. Li
    O. Wang
    Y. Jiang
    R. Liao
    Y. Sun
    J. Dong
    W. Xia
    Osteoporosis International, 2016, 27 : 1047 - 1055